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Background: This study investigated effects on cardiovascular parameters during anaesthesia with isoflurane
(ISO, 2–3 Vol%), ketamine-xylazine (KX, 100 mg•kg−1 + 5 mg•kg−1) or a combination of medetomidine-midazolam-
fentanyl (MMF, 0.15 mg•kg−1 + 2.0 mg•kg−1 + 0.005 mg•kg−1) in rats throughout induction, maintenance and
recovery from anaesthesia. Rats were instrumented with a telemetric system for the measurement of systolic,
diastolic and mean arterial pressure (SAP, DAP, MAP), pulse pressure (PP), heart rate (HR) and core body
temperature (BT). The parameters were continuously measured before, during and after each type of anaesthesia.
Forty minutes after induction, ISO delivery was terminated and MMF was antagonized with atipamezole-flumazenil-
naloxone (AFN, 0.75 mg•kg−1 + 0.2 mg•kg−1 + 0.12 mg•kg−1) whereas KX was not antagonized.
Results: Differences were observed between anaesthesias with KX (301 min) lasting much longer than MMF
(45 min) and ISO (43 min). HR in ISO (x = 404 ± 25 bpm) increased during the time of surgical tolerance whereas
a HR decrease was observed in KX (x = 255 ± 26 bpm) and MMF (x = 209 ± 24 bpm). In ISO (MAP during time of
surgical tolerance: x = 89 ± 12.3 mmHg) and KX (MAP during wake-up period: x = 84 ± 8.5 mmHg) mild hypotensive
values were observed, whereas blood pressure (BP) in MMF (MAP during time of surgical tolerance: x = 138 ±
9.9 mmHg) increased. Despite keeping animals on a warming pad, a loss of BT of about 1°C was seen in all groups.
Additionally, we observed a peaked increase of HR (x = 445 ± 20 bpm) during the wake-up period with ISO and an
increase of PP (x = 59 ± 8.5 mmHg) in MMF during the time of surgical tolerance.
Conclusion: The anaesthesias influenced very differently the cardiovascular parameters measured in Wistar rats. ISO
caused mild hypotension and increased HR whereas MMF produced a marked hypertension and a significant decrease
of HR. The slightest alterations of BP, HR and BT were observed using KX, but the long wake-up and recovery period
suggest the need for prolonged monitoring.
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The rat is a commonly used animal in research and for
many experimental procedures anaesthesia is required
or recommended [1,2]. In the selection of an optimal an-
aesthetic agent to use, the considerations include: 1) ease
of handling, 2) a low-stress induction and recovery, 3)
minimal impact on physiological parameters and thereby
the research results, 4) the ability to adjust the level of
anaesthesia or to prolong it if necessary and, when
needed, 5) a rapid recovery from the anaesthesia. Since a
given anaesthesia regime may influence experimental
outcomes, the choice of a suitable anaesthesia has to be
considered carefully in regard to the experimental re-
quirements [1,3]. The influence of different anaesthetics
on cardiovascular and respiratory parameters, body
temperature, circadian rhythm, blood values, locomotor
activity, intracranial pressure or even on cognitive skills
has been the subject of previous studies [4-14]. It was
also shown that responses to anaesthetics may be strain-
dependent [1,15]. However, the methods for assessing ef-
fects on arterial blood pressure (BP) in many studies
were limited, data collection was too short, or the data
analysis was inadequate to detect potentially important
alterations. Thus, the purpose of this study was to pro-
vide an accurate and continuous assessment of the car-
diovascular effects of three commonly used anaesthetic
regimen in rats. We therefore compared inhalational an-
aesthesia using isoflurane (ISO), with an intramuscular
(i.m.) combination of ketamine and xylazine (KX) as well
as a completely antagonizable anaesthesia using the com-
bination of medetomidine, midazolam and fentanyl (MMF)
administered i.m. in adult male Wistar rats instrumented
for the continuous, telemetric collection of cardiovascular
parameters.
The use of ISO increased over the last years, although
specialized equipment is required for an inhalational an-
aesthesia [16]. ISO has little influence on metabolism be-
cause of an almost complete elimination via exhaled air
and it offers simple handling in deepening and prolonga-
tion of anaesthesia which could be reasons for its in-
creased use [1,3,17]. However, for painful procedures
one should supplement ISO with analgesics due to its
weak analgesic properties [18]. KX is a routinely used
anaesthetic mixture in laboratory animals, although it is
not always recommended as a suitable anaesthetic com-
bination for use specifically in rats [3,16,19-21]. MMF is
commonly used in Germany, although it is not as com-
mon as KX or ISO in other countries. Therefore, experi-
mental data concerning MMF anaesthesia are limited.
This anaesthesia offers the advantage of a rapid and
complete reversal by using an injection of atipamezole,
flumazenil and naloxone (AFN) [20,22-25]. Anaesthesia
in rodents influences diurnal rhythm and often results in
hypothermia and hypoglycemia because of their highmetabolic rate and their large surface area to body
weight ratio [3,20,26-28]. Due to a fast resumption of
food and water intake because of a very short recovery
period when antagonized and, by our experience, its ex-
cellent survival rate, MMF seems to be advantageous
over other anaesthesias in rodents. One important point
to consider with MMF is the reversal of analgesia by na-
loxone. Postoperative pain management has to be pro-
vided by other compounds than opioids or one has to
keep into consideration a partial antagonization with an
opioid-agonist/antagonist or partial agonist such as butor-
phanol or buprenorphine [29-32]. Despite these possible
advantages or disadvantages of these three anaesthesia re-
gimes, there is little data on their cardiovascular effects
throughout induction, maintenance and recovery from the
anaesthesia, effects that could be decisive for the selection
of the optimal anaesthesia for a given setting.
To ensure high quality data, we used rats implanted
with a telemetry device to provide continuous, state-of-
the-art monitoring of cardiovascular parameters [33-36].
Telemetry technology allows group-housing conditions
and measurement in freely moving rats, without the
need for a stressful restraint. The data is also not influ-
enced by an additional anaesthesia performed a few days
or only hours prior to an experiment, to implant an ex-
teriorized catheter for measuring blood pressure [37].
The aim of this study was to show alterations in cardio-
vascular parameters including systolic arterial pressure
(SAP), diastolic arterial pressure (DAP), mean arterial
pressure (MAP), pulse pressure (PP), heart rate (HR) and
core body temperature (BT) during ISO, KX and MMF
anaesthesia in male Wistar rats at specific stages of anaes-
thesia (induction, maintenance and recovery).
Methods
Animals
Twelve, male Wistar rats with a mean body weight of
287 ± 30 g were acquired from a commercial breeder
(Charles River Laboratories, Sulzfeld, Germany). These
animals were housed in groups of three in a Makrolon®
cage (Type IV) containing a wooden bedding material
(Lignocel select fine, J. Rettenmaier & Söhne GmbH +
Co. KG, Rosenberg, Germany). Cage bedding changes
were performed twice weekly. Two red, transparent plas-
tic tubes, nesting material and a wooden chewing block
were provided in each cage for animal enrichment.
The rats received a commercially available diet (3438
maintenance diet, KLIBA NAFAG, Provimi Kliba AG,
Kaiseraugst, Switzerland) and tap water ad libitum. The
animal room was maintained at 22 ± 2°C and 55 ± 10%
relative humidity and there was an air change of at least
15 cycles/hour. Light was on from 6:00 am to 6:00 pm,
starting and ending with a dimmer-period of 30 minutes.
Together with the light, a radio was turned on. The rats
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the husbandry procedures for at least two weeks prior to
the surgical implantation of the radiotelemetry transmitter
(see below).
Implantation of the radiotelemetry transmitter
The implantation of the transmitter (DSI PhysioTel™
C50-PXT) was performed under general anaesthesia
using MMF in the same dosage as described below in
this study. One third of the initial dosage was adminis-
tered again after 45 minutes in order to maintain anaes-
thesia. For analgesia, the rats received prior to surgery
50 mg•kg−1 metamizole i.m. (Novalgin®, 500 mg•ml−1,
Sanofi Aventis, Frankfurt/Main, Germany) and 1 mg•kg−1
meloxicam s.c. (Metacam®, 20 mg•ml−1, Boehringer
Ingelheim, Ingelheim/Rhein, Germany). Metamizole ap-
plication was repeated three times until the next day.
To prevent a bacterial infection, 10 mg•kg−1 enrofloxacin
(Baytril® 2.5% ad us. vet., Bayer, Leverkusen, Germany) was
administered subcutaneously after the analgesic injections.
As soon as the rats lost their righting reflex, the ventral
site of the rat was shaved and then disinfected with
Kodan®-spray (Schülke & Mayr, Norderstedt, Germany)
and Betaisodona®-solution (Mundipharma GmbH, Limburg
(Lahn), Germany). Protective eye lubricant (VitA-POS,
Ursapharm, Saarbrücken, Germany) was administered to
both eyes, loss of body temperature was minimized using
a warm water heating pad and supplemental oxygen was
provided through a nose cone. Once a surgical level of
anaesthesia was confirmed through the loss of reflexes, an
incision was made in the linea alba from below the ster-
num to the umbilical region to open the abdominal cavity.
The intestinal tract was carefully repositioned using a
moist swab in a cranial direction to exposure the aorta
abdominalis which was dissected free for insertion of the
blood pressure catheter of the telemetry unit. Blood flow
was temporarily stopped using two vascular clips and
the catheter was inserted between them and fixed in
place with tissue glue (Histoacryl®, B.Braun, Aesculap
AG, Tuttlingen, Germany). Clips and the swab were then
removed and the transmitter was sutured to the abdom-
inal wall (Mersilene® 3–0, Ethicon®, Johnson-Johnson
Medical GmbH, Norderstedt, Germany). The ECG leads
were exteriorized through the abdominal muscle layer
and placed subcutaneously, one to the end of the ster-
num and the other to the ventral region of the trachea.
The ECG leads were sutured to the nearby muscle tissue
(Mersilene® 3–0, Ethicon®, Johnson-Johnson Medical
GmbH, Norderstedt, Germany). The abdominal cavity was
closed in layers with first a muscle and then a skin suture
(Vicryl® 3–0, Ethicon®, Johnson-Johnson Medical GmbH,
Norderstedt, Germany). At the end of the procedure the
rats received 20 ml•kg−1warmed lactated ringer’s solution
(Ringer-Lactat nach Hartmann B. Braun, B. Braun,Melsungen, Germany) subcutaneously. The anaesthesia
was then antagonized with a subcutaneous injection of
AFN (same dosage as used in this study, see below). The
whole implantation procedure took 90 minutes on aver-
age. Meloxicam was administered once-daily for two add-
itional days. The rats were allowed two weeks to recover
from this surgical procedure before entering the study.
Experimental design
The three different anaesthetic treatments were evalu-
ated using a randomized, crossover design with each rat
receiving each of the following three anaesthetic treat-
ments on different days: 1) an inhalational anaesthesia
with isoflurane for 40 minutes (Forene® 100% (V/V),
Abbott, Wiesbaden, Germany), 2) a combination of keta-
mine (Ketavet®, 100 mg•ml−1, Pfizer, Berlin, Germany)
and xylazine (Rompun® 2%, 20 mg•ml−1, Bayer, Leverkusen,
Germany) administered intramuscularly and 3) a com-
bination of medetomidine (Domitor, 1 mg•ml−1, Orion
Pharma, Espoo, Finland), midazolam (Dormicum®, 5 mg/ml,
Roche, Grenzach-Wyhlen, Germany) and fentanyl (Fentanyl®-
Janssen, 0.05 mg•ml−1, Janssen, Wien, Austria) adminis-
tered intramuscularly and reversed after 40 minutes with
a subcutaneous injection of atipamezole (Antisedan®,
5 mg•ml−1, Orion Pharma, Espoo, Finland), flumazenil
(Flumazenil Hexal®, 0.1 mg•ml−1, Hexal, Holzkirchen,
Germany) and naloxone (Naloxon Inresa, 0.4 mg•ml−1,
Inresa, Freiburg, Germany). With KX anaesthesia the rats
received no treatment to reverse the anaesthesia. The rats
were allowed a recovery period of two weeks between the
anaesthesias. To allow for a thorough monitoring of each
individual rat during anaesthesia, only three anaesthesias
were performed per day. SAP, DAP, MAP, PP, HR and BT
were continuously measured from the start of measure-
ments (6.00 am) until the end of measurements (~5 pm).
A complete measurement consisted of a 2–4 hour pre-
treatment acclimatization period for reaching baseline
values, the time for performing anaesthesia (a duration of
40 minutes was chosen for ISO and MMF anaesthesia; KX
anaesthesia lasted in some animals up to 395 minutes, be-
cause it was not reversed), a wake-up and a recovery
period. All anaesthesias were performed by the same vet-
erinarian to reduce variability.
The experimental procedures were approved by the
Animal Care and Ethics Committee of the Regional
Authority in Tuebingen, Baden-Wuerttemberg, Germany
(Approval number: 12–038).
Procedure
Before starting the telemetric measurement, each rat
was weighed and placed individually into a Makrolon®
cage, containing bedding material and a red, transparent
plastic tube and covered with a cloth. Single housing
and withdrawal of food were required, because rats had
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water was provided in a water bottle during the entire
time of data collection. Each cage was placed on a radio-
frequency receiver plate. A water heating pad was placed
between the cage and the telemetric receiver plate and it
was left on (38°C) throughout the study. Data collection
started by switching on the radiotransmitter using a
magnet, the operator left the room and the animals were
given at least two hours to establish resting, baseline
conditions. Afterwards, the induction of anaesthesia was
started with the first rat. It was of note that this proced-
ure seemed to have no impact on the cardiovascular pa-
rameters measured from the other two rats in the room.
Their cages were still covered with a cloth and anaesthe-
sia was performed as quiet as possible so that the pro-
duced noise did not drown out the radio, which was
switched on at the beginning of measurements. Each rat
received protective eye lubricant (VitA-POS, Ursapharm,
Saarbrücken, Germany) at the beginning of anaesthesia.
After induction of anaesthesia, the righting reflex (de-
fined as positive, when a rat, placed on its back/side, im-
mediately turns over to the normal position with all four
feet on the ground) and pedal withdrawal reflex on the
hind and forelimbs were monitored and classified (+, ±, −)
after 2.5, 5, 7.5, 10, 15, 20, 30, 40, 42.5, 45, 47.5, 50, 60,
70… minutes until the righting reflex had returned.
The time until loss and later regaining of the righting
reflex was determined. Based on the presence or ab-
sence of the reflexes assessed, the anaesthesia time was
divided into the following intervals: 1) the induction
time defined as the time from application of the anaes-
thetic(s) to loss of the righting reflex, 2) the time of
non-surgical tolerance, defined as the time from the
loss of the righting reflex until loss of the pedal with-
drawal reflexes on the hind and forelimbs, 3) the time
of surgical tolerance, defined as the time from the ab-
sence of righting and pedal withdrawal reflexes until
regaining at least one pedal withdrawal reflex, 4) the
wake-up period, describing the time from regaining
one pedal withdrawal reflex until regaining the righting
reflex and 5) the time of recovery, defined as the time
from regaining the righting reflex until the end of mea-
surements. The measurements were terminated not
earlier than six hours after induction for all three an-
aesthesias. Because of long-lasting effects of KX, mea-
surements continued for at least two hours after the
rats regained the righting reflex.
The different anaesthetic treatments were performed
as described below.
ISO
A whole body chamber was prefilled with 5 Vol % ISO
in 100% oxygen. The chamber was placed on the transmit-
ter receiver plate and the rat was positioned into thechamber and the time was measured till loss of the right-
ing reflex. To assess the righting reflex, the chamber
with the animal was tipped over. The rat was then
placed in dorsal recumbency in the middle of the water
heating pad and 5 Vol % ISO was further administered
using a nose cone. The concentration of ISO was then
individually regulated and reduced to 2–3 Vol % for
producing a depth of anaesthesia suitable for surgical
procedures, which meant that all reflexes tested had to
disappear. Forty minutes after induction of anaesthesia,
ISO administration was stopped and the rat was put back
in its cage on the receiver. The rat was positioned on its
back, so that return of the righting reflex could be deter-
mined, when the animal turned around to a ventral
recumbency.
KX
Ketamine (100 mg•kg−1) and xylazine (5 mg•kg−1) were
mixed together in one syringe. The volume of the KX in-
jection was too large (1.25 ml•kg−1) to be administered
in one hind leg, therefore, it was divided in half and
injected intramuscularly in the caudal parts of the fem-
oral musculature of both hind legs. For a continuous
telemetric measurement even during this procedure, the
injection was performed next to the receiver plate to as-
sure capture of the telemetric signals. After loss of the
righting reflex, the rat was placed on its back in the mid-
dle of the heating pad and supplied with 100% oxygen
using a nose cone. Due to the fact that the duration of
this anaesthesia could not be accurately predicted, the
rat stayed on the heating pad until its righting reflex
returned. Thereafter, the animal was immediately placed
back in its cage located on the receiver. The long sleep-
ing and recovery time in KX anaesthesia necessitated the
administration of fluids and therefore all rats received
5 ml of warmed lactated ringer’s solution (Ringer-Lactat
nach Hartmann B. Braun, B. Braun, Melsungen, Germany)
subcutaneously one hour after induction.
MMF
Medetomidine (0.15 mg•kg−1), midazolam (2.0 mg•kg−1)
and fentanyl (0.005 mg•kg−1) were mixed in one syringe
(total volume: 0.65 ml•kg−1) and were administered
intramuscularly in the caudal part of the femoral muscu-
lature of one hind leg. After loss of the righting reflex
the cage was removed and the rat was placed in dorsal
recumbency in the middle of the heating pad and 100%
oxygen was provided using a nose cone. The antagonists
atipamezole (0.75 mg•kg−1), flumazenil (0.2 mg•kg−1)
and naloxone (0.12 mg•kg−1) were mixed in one syringe
and administered subcutaneously 40 minutes after induc-
tion of the anaesthesia. Thereafter, the rat was returned to
its cage in dorsal recumbency to determine the moment
of righting.
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NOTOCORD-hem™ was used for telemetric data acqui-
sition and data were further evaluated using MS Excel.
Values for each parameter over 10 minutes were sum-
marized by the assessment of mean baseline values.
Baseline values were calculated as the mean of the mea-
surements starting 60 up to 10 minutes before the induc-
tion of anaesthesia. Mean values measured during and
after anaesthesia were calculated with medians based on
20 second intervals. For data import from MS Excel the
software package SAS 9.2 was used. The statistical evalu-
ation was done using the software package SAS 9.3 (SAS
Institute Inc., Cary, North Carolina, USA). The statistical
evaluation was done for each parameter measured (SAP,
DAP, MAP, PP, HR and BT) and each of the defined inter-
vals (induction time, time of non-surgical tolerance, time
of surgical tolerance, wake-up and recovery period). The
area under the curve (AUC) was calculated for each
animal individually using the trapezoidal rule for the in-
tervals. The different intervals were compared to the
baseline interval by an analysis of variance (ANOVA)
for repeated measurements for every anaesthesias sep-
arately. Effects were quantified by mean differences and
their two-sided 95% confidence interval. Additionally,
the parameters were analysed by a one-factorial analysis of
covariance (ANCOVA) with heteroscedastic variances and
the fix factor treatment including the baseline as covariate.





Treatment effects were quantified by mean differences,
based on the adjusted mean values, and their two-sided
95% confidence interval. The level of significance for
both analysis was fixed at α = 5%. A p-value less than
0.05 was considered to be statistically significant.Results
In the course of experiments three rats developed a poor
quality blood pressure signal; in two rats it occurred be-
tween the first and the second anaesthesia and in one
rat between the second and third anaesthesia. Therefore
two ISO, two MMF and one KX measurements were not
available for the statistical analysis. Furthermore an an-
aesthetic emergency occurred during one MMF anaes-
thesia and one rat receiving KX anaesthesia never
reached the anaesthetic stage of surgical tolerance. These
animals were excluded from further analysis. Conse-
quently, ten ISO, ten KX and nine MMF measurements
were included in the statistical analysis.All haemodynamic data and body temperature are
summarized in Table 1 and the statistical analysis for the
comparison of anaesthetic treatments is found in Table 2.
There were no relevant differences in baseline values
among the three treatment groups. The PP in KX
(25 mmHg) was, however, slightly lower than that seen
in ISO (31 mmHg) or MMF (31 mmHg).
Figure 1 shows the mean durations of the anaesthetic
stages for ISO, KX and MMF anaesthesia. The durations
of induction time (40 sec) and time of non-surgical tol-
erance (3 min) in ISO were shorter compared to those
using KX (4 min, 6 min) and MMF (5 min, 8 min). Sur-
gical tolerance using ISO and MMF lasted for 40 minutes
after induction, since ISO delivery was then stopped and
MMF was reversed with its antagonists at this point in
time. KX anaesthesia was not reversed and the duration
of surgical tolerance (110 min) was much longer com-
pared to those of ISO (36 min) or MMF (28 min). The
duration of the wake-up period in ISO (3 min) and
MMF (4 min) were comparable and much shorter than
the wake-up period of KX (182 min).
ISO
During induction time SAP, DAP and MAP increased
significantly to 133, 97, and 109 mmHg, respectively. PP
increased significantly to 36 mmHg, HR increased sig-
nificantly to 381 bpm and BT remained stable at 37.4°C.
PP (35 mmHg), HR (369 bpm) and BT (37.3°C) showed
only a slight reduction from induction to the time of
non-surgical tolerance but remained significantly in-
creased. SAP (120 mmHg), DAP (85 mmHg) and MAP
(96 mmHg) decreased almost to their baseline values
and showed no significant differences compared to their
baseline values. During surgical tolerance PP remained
significantly increased with 33 mmHg. SAP decreased
to 111 mmHg, DAP and MAP decreased significantly
to 78 and 89 mmHg, respectively. HR increased signifi-
cantly to 404 bpm and BT decreased significantly to
36.6°C. BP values (SAP 126 mmHg, DAP 89 mmHg,
MAP 101 mmHg, PP 37 mmHg) started to increase
during the wake-up period. HR reached a peak of
445 bpm and BT decreased significantly further to
36.4°C. During recovery time, HR partially normalized
to 300 bpm but was still significantly increased com-
pared to baseline and BT returned to the baseline
value (37.3°C). BP returned almost to baseline values
(SAP 119 mmHg, DAP 90 mmHg, MAP 100 mmHg,
PP 30 mmHg) as well but with still significant in-
creases in DAP and MAP compared to baseline.
KX
BP values (SAP 144 mmHg, DAP 113 mmHg, MAP
123 mmHg, PP 31 mmHg) and HR (371 bpm) increased
significantly during the induction time, whereas BT
Table 1 Mean values with standard deviation
Parameter Treatment Baseline Induction time Non-surgical tolerance Surgical tolerance Wake-up period Recovery
Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD
SAP (mmHg) ISO 118 ± 8.2 133 ± 11.2* 120 ± 21.5 111 ± 12.9 126 ± 10.8* 119 ± 6.2
KX 117 ± 7.0 144 ± 10.5* 129 ± 19.1* 111 ± 14.3 99 ± 8.1* 113 ± 10.3
MMF 120 ± 9.1 167 ± 14.1* 170 ± 12.7* 177 ± 15.1* 113 ± 10.0 117 ± 5.2
DAP (mmHg) ISO 87 ± 5.8 97 ± 9.5* 85 ± 19.2 78 ± 12.1* 89 ± 9.1 90 ± 4.6*
KX 92 ± 9.1 113 ± 8.9* 99 ± 17.3 85 ± 14.2* 76 ± 9.6* 86 ± 5.9
MMF 89 ± 5.9 124 ± 8.9* 121 ± 9.3* 118 ± 7.6* 86 ± 7.9 91 ± 4.5
MAP (mmHg) ISO 97 ± 6.5 109 ± 10.0* 96 ± 19.9 89 ± 12.3* 101 ± 9.6 100 ± 5.0*
KX 100 ± 8.0 123 ± 8.9* 109 ± 17.7* 93 ± 13.9* 84 ± 8.5* 95 ± 6.5
MMF 99 ± 6.9 138 ± 10.6* 137 ± 10.1* 138 ± 9.9* 95 ± 8.5 100 ± 4.6
PP (mmHg) ISO 31 ± 3.8 36 ± 3.5* 35 ± 3.4* 33 ± 2.9* 37 ± 3.7* 30 ± 2.7
KX 25 ± 5.9 31 ± 6.7* 30 ± 5.9* 26 ± 6.8 23 ± 7.0* 27 ± 8.7
MMF 31 ± 3.8 43 ± 5.7* 50 ± 5.9* 59 ± 8.5* 27 ± 3.1* 26 ± 2.4*
HR (bpm) ISO 293 ± 18.1 381 ± 35.1* 369 ± 22.0* 404 ± 24.5* 445 ± 20.0* 300 ± 14.1*
KX 281 ± 22.7 371 ± 33.9* 271 ± 24.0 255 ± 25.7* 289 ± 31.3 316 ± 17.1*
MMF 293 ± 32.9 303 ± 30.2 229 ± 20.9* 209 ± 24.0* 255 ± 28.6* 286 ± 22.5
BT (°C) ISO 37.34 ± 0.17 37.38 ± 0.23 37.33 ± 0.26 36.56 ± 0.55* 36.39 ± 0.71* 37.34 ± 0.16
KX 37.34 ± 0.26 37.27 ± 0.25 37.22 ± 0.22 36.78 ± 0.41* 36.95 ± 0.53 37.55 ± 0.45
MMF 37.49 ± 0.41 37.43 ± 0.40 37.30 ± 0.51 36.90 ± 0.86* 36.54 ± 0.93* 37.25 ± 0.43
No. of animals per treatment: ISO n = 10, KX n = 10, MMF n = 9.
*statistically significant difference (p value ≤ 0.05) based on the ANOVA for the comparison of anaesthetic intervals versus baseline.
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non-surgical tolerance a reduction was observed in all
parameters. PP (30 mmHg) was still significantly in-
creased and BT (37.2°C) was not significantly affected.
BP values (SAP 129 mmHg, DAP 99 mmHg, MAP
109 mmHg) and HR (271 bpm) came close to baseline
values but SAP and MAP showed still a significant in-
crease. From non-surgical to surgical tolerance all pa-
rameters showed a decrease and, except PP, reached
levels lower than their baseline values (SAP 111 mmHg,
DAP 85 mmHg, MAP 93 mmHg, PP 26 mmHg, HR
255 bpm, BT 36.8°C). The difference was significant for
DAP, MAP, HR and BT. A significant decrease still could
be observed during wake-up period (SAP 99 mmHg,
DAP 76 mmHg, MAP 84 mmHg, PP 23 mmHg), except in
HR (289 bpm) and BT (37.0°C) which showed values close
to their baseline. BP values increased (SAP 113 mmHg,
DAP 86 mmHg, MAP 95 mmHg, PP 27 mmHg) once the
animals had righted themselves and values returned almost
to baseline. HR significantly increased to 316 bpm and BT
continued to increase to a final value of 37.6°C.
MMF
Significant increases in BP values (SAP 167 mmHg,
DAP 124 mmHg, MAP 138 mmHg, PP 43 mmHg) were
observed during the induction time. HR (303 bpm) andBT (37.4°C) did not change significantly from their
baseline values. PP (50 mmHg) and SAP (170 mmHg)
continued to increase significantly during the time of
non-surgical tolerance and MAP (137 mmHg) and DAP
(121 mmHg) showed no great alteration compared to in-
duction time but remained significantly increased. A de-
crease in HR (from 303 to 229 bpm) was observed from
induction time to time of non-surgical tolerance and BT
was not significantly affected. During time of surgical
tolerance PP reached a maximum of 59 mmHg with a
SAP of 177 mmHg, a DAP of 118 mmHg and a MAP of
138 mmHg. HR and BT significantly decreased to
209 bpm and 36.9°C, respectively. During the wake-up
period initiated by the administration of the three antag-
onists, BP parameters (SAP 113 mmHg, DAP 86 mmHg,
MAP 95 mmHg, PP 27 mmHg) decreased to levels
lower than baseline values, but this change from baseline
was only significant for PP. HR (255 bpm) remained sig-
nificantly decreased. BT further decreased to 36.5°C dur-
ing wake-up period. BP values (SAP 117 mmHg, DAP
91 mmHg, MAP 100 mmHg), HR (286 bpm) and BT
(37.3°C) returned back to baseline values during the time
of recovery, except PP (26 mmHg), where a significant
decrease still could be observed.
As demonstrated in Figures 2, 3, 4 and 5 (MAP, PP,
HR, BT) the measured parameters showed differences
Table 2 P values based on the ANCOVA
Parameter Treatment Induction time Non-surgical tolerance Surgical tolerance Wake-up period Recovery
Mean difference P value Mean difference P value Mean difference P value Mean difference P value Mean difference P value
SAP (mmHg) ISO vs. KX -13.18 < 0.01* -9.15 0.15 -0.58 0.88 26.46 < 0.01* 6.33 0.07
ISO vs. MMF -33.07 < 0.01* -45.79 < 0.01* -63.08 < 0.01* 15.41 < 0.01* 3.54 0.03*
KX vs. MMF -19.88 < 0.01* -36.64 < 0.01* -62.50 < 0.01* -11.05 0.03* -2.80 0.38
DAP (mmHg) ISO vs. KX -13.57 < 0.01* -7.27 0.27 -1.72 0.70 16.39 < 0.01* 5.96 0.01*
ISO vs. MMF -27.08 < 0.01* -33.41 < 0.01* -38.62 < 0.01* 4.83 0.21 -0.95 0.52
KX vs. MMF -13.50 < 0.01* -26.14 < 0.01* -36.90 < 0.01* -11.56 < 0.01* -6.92 < 0.01*
MAP (mmHg) ISO vs. KX -13.12 < 0.01* -7.33 0.25 -0.90 0.83 19.57 < 0.01* 6.14 0.02*
ISO vs. MMF -29.09 < 0.01* -37.48 < 0.01* -46.74 < 0.01* 8.32 0.05* 0.54 0.71
KX vs. MMF -15.98 < 0.01* -30.16 < 0.01* -45.84 < 0.01* -11.25 < 0.01* -5.60 0.03*
PP (mmHg) ISO vs. KX -0.76 0.59 2.10 0.26 2.68 0.15 8.41 < 0.01* -0.44 0.80
ISO vs. MMF -6.41 < 0.01* -13.95 < 0.01* -25.42 < 0.01* 11.09 < 0.01* 4.55 < 0.01*
KX vs. MMF -5.65 < 0.01* -16.05 < 0.01* -28.10 < 0.01* 2.69 0.20 4.99 0.02*
HR (bpm) ISO vs. KX 14.62 0.36 93.14 < 0.01* 144.75 < 0.01* 148.62 < 0.01* -20.86 < 0.01*
ISO vs. MMF 85.80 < 0.01* 139.93 < 0.01* 195.12 < 0.01* 190.22 < 0.01* 13.41 0.09
KX vs. MMF 71.17 < 0.01* 46.79 < 0.01* 50.37 < 0.01* 41.60 < 0.01* 34.27 < 0.01*
BT (°C) ISO vs. KX 0.11 0.11 0.10 0.26 -0.22 0.34 -0.56 0.08 -0.21 0.18
ISO vs. MMF 0.09 0.26 0.16 0.20 -0.19 0.52 -0.04 0.92 0.19 0.17
KX vs. MMF -0.01 0.87 0.06 0.67 0.03 0.90 0.52 0.14 0.39 0.04*



















Figure 1 Mean duration of ISO, KX and MMF anaesthesia. Anaesthesias were divided in different anaesthetic stages. Induction time (time
from application to loss of righting reflex), time of non-surgical tolerance (time from loss of righting reflex until loss of all measured reflexes), time
of surgical tolerance (time from loss of all measured reflexes till regain of one reflex), wake-up period (time from regaining one reflex till regain of
righting reflex). After 40 minutes ISO delivery was terminated and MMF was reversed with AFN.
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sons of the three treatments with each other are presented
in Table 2. Most prominent differences in haemodynamic
parameters were observed during anaesthesia if MMF was
compared either with ISO or KX. ISO compared with KX
showed significant differences in BP values only during in-
duction time, wake-up period and recovery. Significant
differences in HR were observed almost in all anaesthetic
stages comparing ISO, KX and MMF among each other.
On the other hand, BT did not differ significantly between
the anaesthesias during the different phases, except during
recovery if comparing KX with MMF.Figure 2 Mean arterial blood pressure (mmHg). Individual and mean tiDiscussion
The present study was designed to determine the effect of
three anaesthetic regimes (ISO, KX, MMF) in adult, male
Wistar rats on cardiovascular parameters and BT. The
novel use of telemetric data assessment for these parame-
ters provided accurate and continuous measurements. To
our knowledge, such detailed cardiovascular data for ISO,
KX and MMF in the rat have never been reported.
ISO, KX and MMF showed significantly different ef-
fects on cardiovascular parameters and BT. We evalu-
ated continuously the impact of the anaesthesias and
compared them to baseline values assessed in the sameme courses per treatment group.
Figure 3 Pulse pressure (mmHg). Individual and mean time courses per treatment group.
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rat used in this study under low stress conditions dir-
ectly before anaesthetic measurement, because baseline
values found in the literature show a great variability. In
our study mean HR at baseline ranged from 281 to
293 bpm indicating that the rats were well adapted toFigure 4 Heart rate (bpm). Individual and mean time courses per treatmthe experimental environment, because these values are
at the low end of those found in literature (250–
500 bpm) [1,3,20]. Given the comparable baseline data
between the treatment groups, we can attribute subse-
quent changes observed to the three different anaesthe-
sia regimes tested.ent group.
Figure 5 Core body temperature (°C). Individual and mean time courses per treatment group.
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The route of administration is an important consider-
ation. The most convenient and less stressful method to
induce anaesthesia in rats is to use an inhalant, like ISO,
with an anaesthetic chamber for induction [3,21]. We
used the intramuscular route in the other two treatment
groups because intraperitoneal injection may cause more
stress to the animals and there is a risk of up to 30% for
misdirected injections into the gastrointestinal tract or
the urinary bladder [20,38-40]. Furthermore even a small
failure rate of i.p. injections may have serious conse-
quences for analysis and data interpretation [41]. For
MMF the intramuscular application route worked well
but with KX we observed defensive movements of the rats
during injection and in three animals we noticed local tis-
sue necrosis at the injection site one week after anaesthe-
sia. The volumes being injected were comparable for
MMF (0.65 ml•kg−1) and KX (2 × 0.625 ml•kg−1) when
considering that the volume of KX was divided in half
and being injected in the femoral muscles of both hind
legs. Therefore, we propose that the acidic formulation
of ketamine was responsible for this severe tissue ne-
crosis and not the amount of injected anaesthetics.
Other studies have reported local tissue necrosis or
self-mutilation after an intramuscular injection of keta-
mine or combinations including it [42-46]. Due to these
facts the application route for KX and the use of a less
acidic formulation of ketamine should be considered
for further investigations.Duration of anaesthesia
The planned duration of anaesthesia was 40 minutes.
Many types of surgical procedures can be performed
during this timeframe and other comparative studies se-
lected similar durations for anaesthesia [24,25,42-45]. As
shown in Figure 1, ISO and MMF are best suited for this
intention, whereas the mean duration of KX anaesthesia
lasted 301 minutes. MMF was quickly reversed with a
subcutaneous injection of AFN and anaesthesia with ISO
was reversed quickly after stopping ISO delivery. The pos-
sibility of quickly terminating anaesthesia with ISO and
MMF and the resultant short wake-up period provide dis-
tinct advantages compared to KX anaesthesia for some
procedures. The xylazine-dependent portion of the KX
anaesthesia could have been antagonized. In two studies
the α2-adrenoceptor antagonist atipamezole was used after
KX and ketamine-medetomidine anaesthesia in mice, to
reverse the effects of the α2-adrenoceptor agonists, xyla-
zine and medetomidine, respectively. However, it was re-
ported that mice need more time for recovery after early
reversal, compared to a later partial antagonisation after
40 minutes [47,48]. Therefore, if using atipamezole for re-
versal of KX anaesthesia in rats, it has to be considered
which is the most suitable moment for the administration
in this species. In regard to the long duration of wake-up
and recovery period a reversal with atipamezole is recom-
mendable, although ketamine induced effects (increased
muscle tone, increased catecholamine levels) could still be
observed if administering atipamezole- too early [21,49].
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BP was affected variably by the three anaesthetic re-
gimes. Due to handling and anaesthetic administration
stress (i.m. injection or exposure to an irritant gas) SAP,
DAP, MAP and PP increased transiently during adminis-
tration in all of the three regimes. In contrast to ISO
and KX, the BP values with MMF were substantially
higher than with the other two up to and including the
time of surgical tolerance. BP during ISO and KX tended
to decrease compared to their baseline values. BP
values with ISO were lowest during the time of surgical
tolerance with a MAP of 89 mmHg. Vasodilative prop-
erties of ISO can lead to serious hypotension [17,20], but
our lowest measured values never indicated a marked
hypotension. The administration of xylazine, an α2-adre-
noceptor agonist, results in an initial increase in BP but
changes to a long-lasting hypotension. To produce a gen-
eral anaesthesia and to compensate for the negative effects
of xylazine on BP it is recommended to combine xylazine
with the dissociative anaesthetic agent ketamine because
of its stimulating effects on the central nervous system
[20]. Although the combination of KX should therefore
not lead to a marked hypotension, BP continuously de-
creased over a long time to mild hypotensive values al-
most until the rats had regained their righting reflex.
These findings are in accordance with another study,
which showed the most prominent hypotension after
150 minutes of KX anaesthesia in rats [50]. In contrast,
MMF had a completely different effect on BP. MMF has
been reported to provide stable haemodynamic condi-
tions, but a marked decrease of BP after its reversal
[20,24,25]. Values were often only presented as MAP, so
the real extent of the increase of SAP, DAP and PP
remained unclear. Previous studies with MMF anaesthesia
found a notable increase of MAP in rats, but not in rab-
bits, mongolian gerbils and chinchillas [22,24,25,32,51-54].
Another study evaluated MMF in the syrian golden ham-
ster and based on that data is was suspected that different
ages of the hamsters could have had a different effect on
BP [55]. In mice, a decrease of BP parameters to lower
values compared to a KX anaesthesia was reported [56].
Another study described an increase of BP in dogs (bea-
gles) during medetomidin-midazolam-butorphanol and
medetomidin-midazolam-buprenorphine anaesthesia and
a significant decrease after antagonization with atipame-
zole [57]. Based on these various effects of MMF on car-
diovascular parameters, there is the necessity of further
studies, which evaluate the influence of this anaesthetic
combination in different species. MMF in the present
study produced a significant increase in all BP parameters.
With such hypertensive values it is not recommended to
perform surgical procedures on large blood vessels, due to
a greater risk of bleedings. Retrospectively, we noticed that
the implantation of our telemetry device performed underMMF anaesthesia lead to a higher bleeding risk during sur-
gery than when using ISO anaesthesia. The reason for
choosing MMF for the implantation surgery for our study
was the better analgesic properties of MMF compared to
ISO. As described in literature, we also observed a decrease
of BP after injection of the antagonists. Although these
values were lower than their baseline values we do not
consider them to indicate a marked hypotension, especially
since they lasted for less than two minutes. However,
one published study stated that the antagonization of
MMF during an anaesthetic emergency could result in
a haemodynamically critical and life-threatening state
because of the decreased BP [24]. In a further study, the
reversal of MMF after an induced hemorrhagic shock in
rats did not lead to life-threatening haemodynamic condi-
tions [58].
Methods for blood pressure measurement
BP values reported in this study are different from values
reported in other studies. A likely explanation is the
method of measuring BP parameters. The direct mea-
surement of BP in the abdominal aorta as used in the
present study provides more precise data than a tail-cuff
system or an exteriorized catheter in the A. carotis or A.
femoralis [37,59]. Exteriorized catheters, despite routine
flushing, will eventually clot and lose their ability to
transmit high frequency pressure signals. Their utility is
thereby limited and cannot be maintained for as long as
for animals implanted with a telemetry device. Further-
more, a complete recovery from a catheter implantation
surgery under normal group-housing conditions is not
possible. Thus for the present study, using a cross-over
experimental design with adequate washout periods be-
tween the anaesthesias, the implantable telemetry-based
system was clearly advantageous.
Effects on heart rate
Differences in HR were present in all stages of anaesthe-
sia among the groups receiving ISO, MMF and KX. Low
BP values with ISO due to its vasodilative properties
may have led to the observed increase in HR through
baroreceptor activation. The highest HR being observed
during the wake-up period has not been observed previ-
ously. One might expect an increase in BP with the loss
of vasodilative effects of ISO during the wake-up period
with a decrease in HR. However, we noticed that BP as
well as HR increased after terminating ISO delivery,
which may reflect a recovery of sympathetic tone. The
ISO-induced increase of HR should be taken into ac-
count in the design of studies assessing drug-induced ef-
fects. When using MMF or KX, stress associated with
the injection caused an initial increase of HR followed
by a rapid decrease lower than baseline. With KX, the
lowest HR was observed after 30 minutes followed by a
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the measurement. One study described similar findings
of alterations in HR during KX anaesthesia in rats and it
was suggested that the cardiovascular depressant effect
of xylazine overrides the increased sympathetic and re-
duced vagal tone and the adverse effect of baroreceptor
reflex attributed to ketamine [50]. HR during MMF rap-
idly decreased after injection and continued to decrease
slightly until it was antagonized. It is known that the α2-
adrenoceptor agonist medetomidine and the opioid fen-
tanyl can lead to dose-dependent bradycardia [3,20] and
the dosage needed for MMF anaesthesia were associated
with bradycardia. Other studies were in accordance with
this finding as the authors noted a decrease of HR in
rats, rabbits and chinchillas during MMF anaesthesia
until antagonization [24,25,32,51,52].Effects on body temperature
It is known that anaesthetics alter thermoregulation
[3,20]. Hypothermia impedes metabolism of anaesthetics,
prolongs the wake-up period and is a frequent cause of
post-anaesthetic deaths [3,16]. Small animals like rodents
rapidly lose body heat because of their relatively large sur-
face to volume ratio [3,20]. Although there was only a sig-
nificant difference of BT between KX and MMF during
recovery, all anaesthetic regimes showed a notable de-
crease in BT after induction of anaesthesia. MMF and ISO
showed their lowest values during the wake-up period,
whereas BT in KX had its lowest value during time of
surgical tolerance (about 40 minutes after injection).
During the wake-up period a significant decrease of BT
could no longer be observed with KX. We suggest that
the normalization of BT in KX during anaesthesia was
caused by an increased muscle tone due to the catalep-
tic property of ketamine and mainly by a long lasting
wake-up period where animals slowly regain thermo-
regulatory control. The wake-up period durations of MMF
and ISO were too short to produce a significant impact on
BT because of regaining consciousness and thermoregula-
tory control, therefore BT showed normalization only dur-
ing the time of recovery. In contrast to our findings,
another study, evaluating parameters during KX anaesthe-
sia in rats, showed the lowest value of BT at 150 minutes
after injection. In that study it is not mentioned whether
heat was provided during anaesthesia [48]. Compared
to a study which evaluated the effects of KX, MMF and
ISO on BT in mice and observed the greatest decrease
of BT during ISO anaesthesia, our measurements
showed no significant differences in the decrease of BT
during anaesthesia. In that study heat-supply is not only
recommended during anaesthesia, but also during the pre-
anaesthetic period [60]. It seems that proving warmth, as
done in the present study throughout the procedure,cannot completely prevent a decrease of BT during anaes-
thesia, but it may effectively reduce the extent of heat-loss.
Conclusion
Our study compared the haemodynamic effects of ISO,
KX and MMF anaesthesia in chronically instrumented
rats using telemetric data collection.
ISO caused a mild hypotension and a significant in-
crease of HR during anaesthesia. But with ISO, the great-
est increase of HR was observed in the wake-up period.
BP as well as HR decreased significantly using KX and
while HR returned to baseline during wake-up period, BP
continued to decrease until the animals regained con-
sciousness. Marked increases of BP values and a signifi-
cant decrease of HR were observed with MMF. Although
these effects were completely reversed with an injection of
AFN, in MMF the increased bleeding risk when manipu-
lating large blood vessels should be kept in mind.
ISO, KX and MMF all have advantages and disadvan-
tages, but which anaesthesia is most suitable for an experi-
mental investigation depends on the aim of the study.
Without partial antagonization with atipamezole we
would not recommend KX for experimental procedures
requiring a quick recovery and since it caused tissue ne-
crosis at the injection site, when administered i.m.
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